Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus

Clinical trial NCT05359432 · COMPLETED

Trial details

NCT number: NCT05359432
Sponsor: Getz Pharma
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2020-07-01
Primary completion: 2021-08-10
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.